New Chemical Entity

MILWAUKEE, Feb. 22, 2026 — New clinical research presented at the 2026 Annual Meeting of the American Academy of...

WASHINGTON, Feb. 20, 2026 — Vanda Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™...